Biogenesis and molecular characteristics of serum hepatitis B virus RNA

Sheng Shen,Zhanglian Xie,Dawei Cai,Xiaoyang Yu,Hu Zhang,Elena S. Kim,Bin Zhou,Jinlin Hou,Xiaoyong Zhang,Qi Huang,Jian Sun,Haitao Guo
DOI: https://doi.org/10.1371/journal.ppat.1008945
IF: 7.464
2020-10-20
PLoS Pathogens
Abstract:HBV is an enveloped DNA virus that replicates its DNA genome <em>via</em> reverse transcription of a pregenomic (pg) RNA intermediate in hepatocytes. Interestingly, HBV RNA can be detected in virus-like particles in chronic hepatitis B (CHB) patient serum and has been utilized as a biomarker for intrahepatic cccDNA activity in treated patients. However, the biogenesis and molecular characteristics of serum HBV RNA remain to be fully defined. In this study, we found that the encapsidated serum HBV RNA predominately consists of pgRNA, which are detergent- and ribonuclease-resistant. Through blocking HBV DNA replication without affecting pgRNA encapsidation by using the priming-defective HBV mutant Y63D or 3TC treatment, we demonstrated that the cell culture supernatant contains a large amount of pgRNA-containing nonenveloped capsids and a minor population of pgRNA-containing virions. The formation of pgRNA-virion requires both capsid assembly and viral envelope proteins, which can be inhibited by capsid assembly modulators and an envelope–knockout mutant, respectively. Furthermore, the pgRNA-virion utilizes the multivesicular body pathway for egress, in a similar way as DNA-virion morphogenesis. Northern blotting, RT-PCR, and 3' RACE assays revealed that serum/supernatant HBV pgRNA are mainly spliced and devoid of the 3'-terminal sequences. Furthermore, pgRNA-virion collected from cells treated with a reversible HBV priming inhibitor L-FMAU was unable to establish infection in HepG2-NTCP cells. In summary, serum HBV RNA is secreted in noninfectious virion-like particle as spliced and poly(A)-free pgRNA. Our study will shed light on the molecular biology of serum HBV RNA in HBV life cycle, and aid the development of serum HBV RNA as a novel biomarker for CHB diagnosis and treatment prognosis.Although increasing evidence supports the presence of extracellular HBV RNA (or serum HBV RNA) species and their potentials to be a new marker for monitoring chronic HBV infection, the origin and molecular forms of serum HBV RNA remain ill-defined. In addition to the infectious DNA virions, HBV is known to produce a number of incomplete viral particles extracellularly, including subviral particles (HBsAg), naked capsids, and empty virions, during its replication cycle. Here, we demonstrated that HBV pregonomic (pg) RNA-containing virion-like-particles exist in cell culture fluid and patient sera, which are secreted along with mature DNA virions <em>via</em> the multivesicular body (MVB) secretory route. Moreover, virion-derived HBV RNAs are predominantly spliced and 3' truncated forms, and HBV RNA virions are unable to initiate a new round of infection in cell cultures. These findings provide new insights into a better understanding of serum HBV RNA biology and a conceptual basis for further widespread clinical applications of serum HBV RNA as a biomarker in chronic hepatitis B patients.
microbiology,virology,parasitology
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper primarily explores the biogenesis and molecular characteristics of Hepatitis B Virus (HBV) RNA in serum. Specifically, the paper aims to address the following key issues: 1. **Forms of HBV RNA**: - Does HBV RNA in serum exist in virus-like particles? What is its physical form? - Studies indicate that HBV RNA in serum is mainly pregenomic RNA (pgRNA), and this RNA can resist the action of detergents and ribonucleases. 2. **Molecular Characteristics of HBV RNA**: - What are the specific molecular characteristics of HBV RNA in serum? - Research has found that HBV RNA in serum is primarily in a spliced form and lacks the 3' terminal sequence. 3. **Secretion Mechanism**: - How are HBV RNA virus-like particles secreted from liver cells? - Studies show that these particles are secreted via the multivesicular body (MVB) pathway, similar to the secretion method of DNA viruses. 4. **Infectivity**: - Are HBV RNA virus-like particles in serum infectious? - Experimental results indicate that these particles are not infectious. 5. **Clinical Application Potential**: - Can HBV RNA in serum be used as a new biomarker for the diagnosis and treatment evaluation of chronic hepatitis B? - The research provides new insights into the biological characteristics of serum HBV RNA, laying the foundation for its broader application as a biomarker. In summary, this paper provides a new perspective on the biological mechanisms of serum HBV RNA through detailed studies on its biogenesis and molecular characteristics, and offers a theoretical basis for its application in the diagnosis and treatment monitoring of patients with chronic hepatitis B.